Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 11, No 2 (2019) Possible timing for anticoagulation therapy initiation in ischemic stroke patients with atrial fibrillation: further analysis of the hemorrhagic transformation index Abstract  PDF (Eng)  similar documents
M. N. Kalinin, D. R. Khasanova, M. M. Ibatullin
"... and 3 days after the onset of IS. There was a progressive NNT drop in patients with a HTI score of 0–1 ..."
 
Vol 7, No 1 (2015) Possibility of predicting hemorrhagic transformation during reperfusion therapy for ischemic stroke in the patient population of the Sverdlovsk Region Abstract  similar documents
E. V. Prazdnichkova, A. M. Alasheev, A. A. Belkin, L. I. Volkova
"... Hemorrhagic transformation of an infarction focus is the most common and menacing complication ..."
 
Vol 7, No 3 (2015) Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision Abstract  similar documents
Irina Gennadyevna Rudakova, Yu. A. Belova
"... Region under the present-day conditions of drug provision Rudakova I.G., Belova Yu.A. M.F. Vladimirsky ..."
 
Vol 5, No 3 (2013) Analysis of factors influencing the early efficiency of systemic thrombolytic therapy for ischemic stroke Abstract  similar documents
Elena Vladimirovna Prazdnichkova, A M Alasheev, O A Shalagina, L I Volkova
"... . Improvement was observed in 66% of the patients on day 7. The mean NIHSS score on day 7 was 6.0 (range 4–12 ..."
 
Vol 4, No 4 (2012) Clinical social and neurobiological aspects of the assesment of social danger of patients with schizophrenia and organic mental disorders Abstract  similar documents
Andrey Yurjevich Berezantsev, D A Kuznetsov
"... committed unsafe acts and features of transformation syndromes when performing repeated socially dangerous ..."
 
Vol 6, No 3 (2014) Factors influencing the efficiency and safety of systemic thrombolysis in patients with ischemic stroke Abstract  similar documents
N. A. Shamalov, K. V. Anisimov, M. A. Kustova, A. P. Tolmachev
"... . The hemorrhagic transformation of a brain lesion focus in IS is a serious complication of thrombolytic therapy (TT ..."
 
Vol 6, No 3 (2014) Myofascial pain: from Virchow's to our days Abstract  similar documents
I. V. Egorov
"... drugs and further to the increase of their doses because the treatment is ineffective. Modern-day ..."
 
Vol 4, No 2 (2012) Efficacy of paxil in the treatment of depressions in elderly males Abstract  similar documents
N A Tyuvina, S V Prokhorova, T N Maksimova
"... .3%)], and bipolar affective disorder [n = 9 (25.7%)] were examined. The efficacy of paxil 20—40 mg/day ..."
 
Vol 3, No 1 (2011) Experience in using intravenous thrombolysis in ischemic stroke in Tatarstan Abstract  similar documents
Dina Rustemovna Khasanova, T V Demin, Dina Rustemovna Khasanova, T V Demin
"... stroke (IS). Significant positive changes (a neurological deficit decrease on the NIHSS score by ≥ 4 ..."
 
Vol 8, No 2 (2016) Treatment for mixed cognitive impairments and emotional disorders in young and middle-aged patients Abstract  similar documents
V. A. Parfenov, E. Yu. Solovyeva, L. M. Antonenko, A. B. Lokshina, T. Gorskaya
"... ) questionnaire; the mean score of the latter increased from 3.86 at baseline to 4.84 after 3 months of treatment ..."
 
Vol 8, No 1 (2016) Opportunities in multimodal neuroimaging for optimizing thrombolytic therapy for ischemic stroke Abstract  similar documents
M. M. Odinak, I. A. Voznyuk, S. N. Yanishevsky, S. Yu. Golokhvastov, N. V. Tsygan, A. Yu. Polushin, R. V. Andreev, D. A. Mirnaya
"... . With an irreversible tissue damage volume of >60 cm3 on day 1 of stroke, as evidenced by diffusion-weighted MRI ..."
 
Vol 3, No 2 (2011) Therapy for depression in patients with focal epilepsy: experience with citalopram use Abstract  similar documents
Anna Valer'yanovna Lebedeva, E G Melikyan, A B Gekht, Anna Valeryanovna Lebedeva, P I Bilalova, E G Melikyan, A B Gekht
"... to the HADS: the mean scores for anxiety and depression were 13.38±2.15 and 11.19±3.28, respectively. After ..."
 
Vol 5, No 1 (2013) Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease Abstract  similar documents
Oleg Semenovich Levin, V K Datiyeva
"... . The starting dose of the drug was 2 mg/day in all the cases. Then it was increased once weekly until ..."
 
Vol 1, No 3-4 (2009) TREATMENT FOR ACUTE NONSPECIFIC BACK PAIN IN OUTPATIENT PRACTICE Abstract  similar documents
O N Gerasimova, Vladimir Anatol'evich Parfenov, O N Gerasimova, Vladimir Anatolyevich Parfenov
"... techniques. The patients took movalis in a dose of 15 mg/day orally or 15 mg/day intramuscularly for up to 5 ..."
 
Vol 4, No 3 (2012) Experience in correcting brain edema in cerebral infarction Abstract  similar documents
E V Eliseyev, T Yu Nedorostkova, Sofia Alekseyevna Rumyantseva, V V Afanasyev
"... of the disease. The baseline severity of neurological symptoms was 10.2±2.12 scores according to the National ..."
 
Vol 1, No 1 (2009) ETORICOXIB: THERAPEUTIC POTENTIAL Abstract  similar documents
A E Karateev, A E Karateev
"... to 120 mg/day), lower risk of gastrointestinal events, liver damage, and skin and respiratory reactions ..."
 
Vol 8, No 2 (2016) Effect of cerebrolysin on motor function restoration during medical rehabilitation Abstract  similar documents
M. A. Kustova, A. P. Tolmachev, N. A. Shamalov
"... efficiency criterion, the Action Research Arm Test (ARAT) scale, and total outcome 90 days after disease ..."
 
Vol 2, No 2 (2010) Clinical electroencephalographic criteria for the efficacy of rispolept therapy in children with Tourette's syndrome Abstract  similar documents
Valeri Petrovich Zykov, S A Kabanova
"... years who took rispolept in a dose of 2-3 mg/day. The clinical and electroencephalographic assessment ..."
 
Vol 5, No 2 (2013) Neurasthenia: State-of-the-art and therapeutic approaches Abstract  similar documents
Leonid Semenovich Chutko, S Yu Surushkina, I S Nikishena, E A Yakovenko, T I Anisimova
"... as two administrations for 10 days (5 days at a 2-day interval). The results of therapy were assessed ..."
 
Vol 10, No 3 (2018) Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window Abstract  similar documents
K. S. Knni, T. V. Dyomin, L. B. Adeeva
"... deficit, all the patients were divided into three subgroups: 1) mild IS (<8 NIHSS scores at admission); 2 ..."
 
Vol 9, No 1 (2017) The impact of sleep-disordered breathing on early functional recovery in ischemic stroke Abstract  similar documents
G. M. Lutokhin, L. A. Geraskina, A. V. Fonyakin, M. Yu. Maksimova
"... , cardiorespiratory monitoring was performed on 2–5 days after the onset of the disease. The total number of episodes ..."
 
Vol 1, No 2 (2009) VESTIBULAR VERTIGO. EXPERIENCE IN USING BETAVER Abstract  similar documents
Vladimir Anatol'evich Parfenov, O V Abdulina, Vladimir Anatolyevich Parfenov, O V Abdulina
"... ). All the examinees took betaver in a dose of 48 mg/day for 30 days. Betaver treatment resulted ..."
 
Vol 3, No 3 (2011) Electromyography: prognosis and evaluation of the efficiency of therapy for Bell's palsy Abstract  similar documents
N G Savitskaya, D S Yankevich, A V Ostafiychuk, E V Pavlov
"... were shown to be nerve excitability threshold in the acutest period (up to 5 days), M-response ..."
 
Vol 3, No 1 (2011) Current aspects of the epidemiology and treatment of chronic brain ischemiain the presence of essential hypertension (results of the CALIPSO program) Abstract  similar documents
Elena Igorevna Chukanova, Elena Igorevna Chukanova
"... . The patients received dropwise intravenous Cavinton as infusions within the first week (25 mg on days 1 to 4 ..."
 
Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях Surgical and medical treatments for discogenic low back radiculopathy Abstract  similar documents
M. A. Ivanova, V. A. Parfenov, A. O. Isaikin
"... 7–14 days and 0.84 vs 1.56 scores after 3 months; p < 0.05); however, this advantage did not persist ..."
 
Vol 8, No 2 (2016) Vascular and neurodegenerative cognitive impairments: a clinical case report Abstract  similar documents
V. V. Zakharov, N. V. Vakhnina
"... symptoms and the results of instrumental and neuroradiological examinations. The present-day ideas on mixed ..."
 
Vol 5, No 2 (2013) Current possibilities of therapy for sleep disorders in Parkinson’s disease Abstract  similar documents
Marina Romanovna Nodel
"... to antiparkinsonian drugs, melatonin was given in a dose of 3 mg/day. The efficiency of the therapy was evaluated ..."
 
Vol 6, No 2 (2014) Experience with non-drug therapies (psychotherapy, phytotherapy, reflexotherapy) for neurasthenia Abstract  similar documents
S.A Bozhko, N.A. Tyuvina
"... inventory (MFI-20). Results. All the patients underwent a complete treatment cycle for 35 days. After ..."
 
Vol 11, No 2 (2019) Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression Abstract  similar documents
L. I. Abramova, G. P. Panteleeva, I. Yu. Nikiforova, T. E. Novozhenova
"... over time on fixed days from a reduction in the mean total score (MTS) of the respective scales ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments Abstract  similar documents
I.S. Preobrazhenskaya
"... ) with moderate CIs or mild dementia (the total Mini-Mental State Examination (MMSE) scores were 22–28). A study ..."
 
Vol 4, No 3 (2012) Cognitive impairments in young people with opioid addiction and their correction Abstract  similar documents
Maria Lazarevna Chukhlovina
"... /day according to the degree of cognitive impairments for 3 months), there was a significant ..."
 
Vol 4, No 2 (2012) The efficacy and tolerability of paroxetine (adepress), an antidepressant from a group of selective serotonin reuptake inhibitors, in psychoautonomic syndrome within anxiety-depressive disorders Abstract  similar documents
T G Voznesenskaya, N M Fokina
"... (paroxetine) was used in a dose of 10—20 mg/day for 8 weeks. Adverse reactions were observed in one-third ..."
 
Vol 5, No 4 (2013) Cardioembolic stroke: a variety of causes and current approaches to its prevention Abstract  similar documents
Lyudmila Aleksandrovna Geraskina
"... give the present-day views of the role and place of cardiac diseases in the pathogenesis ..."
 
Vol 4, No 1 (2012) Experience in using sulpiride in non-psychotic endogenous depressive-hypochondriacal disorders Abstract  similar documents
Nina Arkadyevna Tyuvina, V. V. Balabanova, E M Goncharova
"... in an initial dose of50—100 mg/day; the dose was, if required, increased up to 400—600 mg/day. Results. After 2 ..."
 
Vol 5, No 3 (2013) Diabetic peripheral neuropathy therapy-induced activation of humoral serotonin and endogenous neurotrophins Abstract  similar documents
Yuulia Vladimirovna Karakulova, N B Kaigorodova, E A Batueva
"... of 10.0 ml for 10 days. Prior to treatment, their pain intensity was 5.94±1.2 and 29.6±6.24 scores ..."
 
Vol 3, No 4 (2011) New possibilities of neuroprotection in ischemic stroke Abstract  similar documents
D V Sergeyev, M A Piradov, M Yu Maksimova, Maksim Alekseyevich Domashenko, A N Sergeyeva, F R Okhtova
"... Reperfusion and neuroprotection are two present-day therapy strategies for patients with acute ..."
 
Vol 2, No 3 (2010) Clinical experience with ceraxon used in ischemic stroke Abstract  similar documents
Vladimir Anatolyevich Parfenov, T G Fateyeva, O V Kosivtsova
"... cerebrovascular diseases. The efficiency and safety of Ceraxon intravenously in a dose of2000 mg/day for 10 days ..."
 
Vol 5, No 1S (2013): Special issue "Epilepsy" Clinical evolution of epileptic seizures in children with perinatal brain pathology Abstract  similar documents
E. A. Morozova, D. V. Morozov, V. A. Karlov
"... and transformation of epileptic seizures in children who have verified perinatal problems. A study of 66 children ..."
 
Vol 5, No 4 (2013) Value of determining the cerebrospinal fluid protein markers of amyloidosis and neurodegeneration in the diagnosis of vascular and neurodegenerative cognitive impairments Abstract  similar documents
Vladimir Yuryevich Lobzin, A Yu Emelin, M M Odinak, L A Alekseeva, N E Monakhova
"... ) and the specific features of their transformation to dementia. Cerebrospinal fluid (CSF) was investigated in 60 ..."
 
Vol 6, No 4 (2014) The specific features and pattern of febrile infection-related epilepsy syndrome (FIRES) in children Abstract  similar documents
L. V. Shalkevich, O. A. Lvova, A. I. Kudlach, V. V. Komir
"... ; acute onset as fever to develop high-frequency focal seizures several days later; the absence ..."
 
Vol 8, No 4 (2016) GLOBAL CLINICAL PRACTICE AND PERSONALIZED CHOICES FOR ORAL ANTICOAGULANT THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Fonyakin, L. A. Geraskina
"...   новых пероральных антикоагулянтов (ПОАК).  Начало клинического применения данных средств открыло новую ..."
 
Vol 2, No 2 (2010) Acetylsalicylic acid in the prevention and treatment of ischemic stroke Abstract  similar documents
Andrey Vladimirovich Fonyakin
"... обязательное выделение категории лиц с повышенным риском ишемических церебральных осложнений. Раннее начало ..."
 
Vol 4, No 2 (2012) Clinical experience with meloxicam (Movalis®) in nonspecific back pain and radiculopathy Abstract  similar documents
O N Gerasimova, V A Parfenov
"... of the treatment in patients with acute, subacute, or chronic pain was 12.1±5.2, 17.1±5.7, and 18.0±7.9 days ..."
 
Vol 3, No 3 (2011) Use of amelotex to treat patients with acute musculoskeletal pain in the back and grade 1 essential hypertension Abstract  similar documents
E V Podchufarova, N N Yakhno
"... of the safety and efficacy of amelotex (meloxicam injectable dosage form) in an intramuscular dose of 15 mg/day ..."
 
Vol 4, No 3 (2012) Thrombolytic therapy in patients with ischemic stroke in the vertebrobasilar system Abstract  similar documents
K V Anisimov, A Yu Vishnyakova, G R Ramazanov, Nikolai Anatolyevich Shamalov, V G Lelyuk, V I Skvortsova
"... scores according to the National Institute of Health (NIHSS) Scale should be performed only within ..."
 
Vol 10, No 1 (2018) Treatment of vertigo in elderly patients with chronic cerebrovascular disease Abstract  similar documents
S. N. Duma
"... who took betahistine 48 mg/day, intravenous Mexidol® 5.0 ml for 10 days, then 375 mg tablets daily ..."
 
Vol 3, No 3 (2011) Cognitive functions in late periods after reconstructive operations on the carotid arteries Abstract  similar documents
T P Evdokimova, N M Lobova, L A Geraskina, P A Fedin, M N Guryev, Yu Rodionov, S I Skrylev
"... ischemic changes in 27 (32%) patients on days 1-2. Results and discussion. As compared to the baseline data ..."
 
Vol 1, No 1 (2009) THE ACUTE PERIOD OF ISCHEMIC STROKE: DIAGNOSIS AND TREATMENT Abstract  similar documents
V A Parfenov, V A Parfenov
"... являются нарушения гемодинамики в различных отделах сосудистого русла. Дм (0,5 мг/кг/день) внутрь у собак ..."
 
Vol 3, No 3 (2011) Poststroke cognitive impairments and their therapy with ceraxon Abstract  similar documents
N V Shakhparonova, A S Kadykov, E Kashina
"... impairments as disorders of memory, attention, and thinking. Results and discussion. Ten-day treatment ..."
 
Vol 1, No 1 (2009) TENOTEN IN COMPLEX THERAPY FOR CEREBROVASCULAR INSUFFICIENCY IN ELDERLY PATIENTS Abstract  similar documents
L D Serova, L D Serova
"... of 20 patients. During 28 days, the study group patients received tenoten as a tablet thrice daily ..."
 
1 - 50 of 623 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)